Researchers have found in a new study that Nemolizumab demonstrated rapid and meaningful symptom relief in patients with ...

Vixarelimab led to rapid, dose-dependent reductions in itch severity compared with placebo, with more than 50% decreases in WI-NRS scores at week 16 in the high- and mid-dose groups, and meaningful ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.